Mmastodon HealthMedicine first seen 10 h ago, last 10 h ago, peak #6
FDA approves Onswik, a once-weekly insulin for type 2 diabetes
Original: The FDA approved Onswik, a once-weekly insulin for type 2 diabetes, but not for type 1. What the trials showed and the s
The FDA has approved Onswik, a once-weekly insulin intended for adults with type 2 diabetes. It was not approved for type 1 diabetes. Coverage highlights what the clinical trials showed about effectiveness and the side effects patients should know about. The approval is drawing attention as a potential convenience shift for diabetes management, reducing injections from daily to weekly.
Why now: A novel once-weekly insulin approval is a significant development for millions managing type 2 diabetes.
Evidence
- The FDA approved Onswik, a once-weekly insulin for type 2 diabetes, but not for type 1. What the trials showed and the side effects to know. # wellness # diabetes # medicine https://www. medicaldaily.com/onswik-weekly… · Econopass@flipboard.com · 2
API: https://socialmediatrends-api.osmike.com/v1/trends/222415